Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIGHTY: Prebiotics and Metformin in T2D Youth
NCT04209075Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Mar 2020
- Primary completion
- Jul 2021
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Primary endpoint: Gastrointestinal Tolerability Score at 1 week. Started Mar 2020; status: completed.
Beyond the preview
Go deeper on NCT04209075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04209075.